BiotechPark with Innovation- and Incubationscenter

diagram

Berlin-Buch, with its long tradition of excellent biomedical basic and clinical research as well as clinical expertise, is an ideal environment for life science companies. The campus atmosphere is conducive to scientific exchange, technology transfer and collaborative projects.

With an area of approximately 45,000 m², the BiotechPark Berlin-Buch is one of the largest biotech parks in Germany. Here entrepreneurs and companies find affordable, industry-specific laboratory and office space with state-of-the-art facilities. Start-ups can grow and thrive in the Innovation and Incubation Center, building areas on the Campus allow for future development. The managing company, Campus Berlin-Buch GmbH, supports the companies in all matters and provides comprehensive service.
Currently, 75 companies are located on campus and employ around 850 people. More than fifty of these companies are in the biotech sector, several others offer services for the life science industry. Since 1998 the number of employees of the biotech companies has more than doubled.

The business fields of the companies range from medical technology products, molecular biological diagnostics and treatments, preclinical pharmacological and pharmacogenomic tests, RNA technologies, the search for pharma-relevant target molecules, production and testing of drugs and the analysis and synthesis of biomolecules.

Since 2023 the new BerlinBioCube start-up center in BiotechPark Berlin-Buch offers an additional 8,000 square meters of laboratory and office space and attractive services for start-ups in the fields of biotechnology and medical technology as well as adjacent areas.

„Made in Buch“ stands for high quality and innovation in the life sciences. Selected products can be found here.

Otto Warburg House

News innovation

Berlin honors outstanding deep-tech companies—including MyoPax

This year, for the first time, a Deep Tech Award was presented in the Bio & Health Tech category. The winner is MyoPax, a spin-off of the Max Delbrück Center and Charité.

more ...

Eckert & Ziegler Receives “Best Managed Companies Award” Once Again

Eckert & Ziegler SE (ISIN DE0005659700) has won the “Best Managed Companies Award” for the third time in a row. With this honor, Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federati...

more ...

Eckert & Ziegler with a Successful Start to the Year. 2026 Forecast Confirmed.

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) increased its sales in the first quarter of 2026 by 7% to €72.9 million compared with the same period last year.

more ...

Events Campus

04.06.2026, 10:00
CRISPR/Cas: Grundlagen und praktische Anwendung

Der Crashkurs für Einsteiger*innen vermittelt die Grundlagen der CRISPR/Cas Technologie. Die Teilnehmer*innen sollen in die Lage versetzt werden, CRISPR/Cas Experimente selbständig zu planen und durch...

more ...

06.06.2026, 17:00
Lange Nacht der Wissenschaften am 6. Juni 2026

Campus Berlin-Buch ist dabei: Von 17 bis 24 Uhr laden dann wieder rund 50 wissenschaftliche und wissenschaftsnahe Einrichtungen in Berlin zu spektakulären Experimenten, spannenden Vorträgen, Wissensch...

more ...

09.06.2026, 09:00
Meet the Biotechpark Berlin-Buch at bio:cap 2026

bio:cap 2026: Premiere of a new Life Science & AI Investival at CityCube Berlin

more ...

Sponsoren der Website: